MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts

Citation
Rs. Boyd et Fr. Balkwill, MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts, BR J CANC, 80(3-4), 1999, pp. 315-321
Citations number
42
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
80
Issue
3-4
Year of publication
1999
Pages
315 - 321
Database
ISI
SICI code
0007-0920(199905)80:3-4<315:MRAAIO>2.0.ZU;2-B
Abstract
The matrix metalloproteinase MMP-2 is up-regulated in epithelial cancers an d its mRNA localizes to stromal fibroblasts. In this paper we show that co- culture of ovarian carcinoma cells with fibroblasts resulted in an enhanced release of proMMP-2 and TIMP-2 into the culture medium. Cell-cell interact ion was a major factor in this response and carcinoma cells stimulated proM MP-2 release from fibroblasts but not vice versa. Collagen 1, in a dose-dep endent fashion, induced activation of proMMP-2 by tumour-derived, but not n ormal, fibroblasts. Antibody to beta(1) integrin also induced proMMP-2 acti vation by tumour-derived fibroblasts. The activation involved the processin g of proMMP-2 by a membrane-bound metalloproteinase. We propose that, in th e ovarian tumour microenvironment, interaction between tumour cells and fib roblasts may enhance fibroblast production of the proMMP-2 and TIMP-2. Coll agen I, also present in the ovarian tumours, then induces these fibroblasts to activate proMMP-2 even in the presence of TIMP-2. This active MMP-2 can associate with the cell surface of tumour cells and fibroblasts and is use d in the processes of tissue remodelling and invasion.